Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation
Publication
, Journal Article
Markert, T; Kolin, DL; Konstantinopoulos, PA
Published in: Gynecologic Oncology Reports
April 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Gynecologic Oncology Reports
DOI
ISSN
2352-5789
Publication Date
April 2022
Volume
40
Start / End Page
100979 / 100979
Publisher
Elsevier BV
Citation
APA
Chicago
ICMJE
MLA
NLM
Markert, T., Kolin, D. L., & Konstantinopoulos, P. A. (2022). Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation. Gynecologic Oncology Reports, 40, 100979–100979. https://doi.org/10.1016/j.gore.2022.100979
Markert, Tahireh, David L. Kolin, and Panagiotis A. Konstantinopoulos. “Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation.” Gynecologic Oncology Reports 40 (April 2022): 100979–100979. https://doi.org/10.1016/j.gore.2022.100979.
Markert T, Kolin DL, Konstantinopoulos PA. Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation. Gynecologic Oncology Reports. 2022 Apr;40:100979–100979.
Markert, Tahireh, et al. “Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation.” Gynecologic Oncology Reports, vol. 40, Elsevier BV, Apr. 2022, pp. 100979–100979. Crossref, doi:10.1016/j.gore.2022.100979.
Markert T, Kolin DL, Konstantinopoulos PA. Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation. Gynecologic Oncology Reports. Elsevier BV; 2022 Apr;40:100979–100979.
Published In
Gynecologic Oncology Reports
DOI
ISSN
2352-5789
Publication Date
April 2022
Volume
40
Start / End Page
100979 / 100979
Publisher
Elsevier BV